Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the third quarter ended September 30, 2025, and refined full year 2025 financial guidance.

Pennsylvania-based Conestoga Capital Advisors sold 855,435 Vertex shares for an estimated $24.8 million based on average ...

Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

ADVERTISEMENT ADVERTISEMENT Breaking News Intern A woman suspected of burglary was snapped in a mugshot with her face covered ...

The startup is advancing a drug licensed from China’s Hengrui Pharma that it claims could be “best-in-class” among a group of ...

03, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) ("Vertex” or the "Company”), a leading global ... and the other factors described under the heading "Risk Factors” in the Company’s Annual ...

In vivo preclinicalproof-of-concept data presented at AHA and ESGCT demonstrating >90% LDL-C reduction in non-human primates supports ...

L-carnitine, also known as levocarnitine, is a naturally occurring amino acid structure that the body produces. It plays a critical role in energy production, converting fat into energy. Most people ...

Apacer (TWSE: 8271), a global leader in industrial memory and storage solutions, will showcase its latest innovations at embeddedworld North America 2025. Visitors will explore Apacer's advancements ...